Valuation Alfresa Holdings Corporation

Stocks

Market Closed - Japan Exchange 02:30:00 2026-10-30 am EDT			5-day change	1st Jan Change
2,469.00 ^JPY	+1.19%		+2.60%	+1.56%

Oct. 05	Healios Completes First 144 Million Yen Culture Supernatant Shipment to JENECEL	MT
Jun. 30	Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	343,826	343,217	415,318	383,847	459,384	433,096	-	-
Change	-	-0.18%	21.01%	-7.58%	19.68%	-5.72%	-	-
Enterprise Value (EV)	168,429	186,950	236,499	242,307	301,938	433,096	433,096	433,096
Change	-	11%	26.5%	2.46%	24.61%	43.44%	0%	0%
P/E	11.1x	13.3x	14.4x	14.3x	11x	18.7x	15.7x	16.4x
PBR	0.73x	0.7x	0.87x	0.8x	0.91x	0.86x	0.83x	0.83x
PEG	-	-0.8x	0.7x	-3.34x	0.2x	-0.4x	0.8x	-4.03x
Capitalization / Revenue	0.13x	0.13x	0.15x	0.13x	0.15x	0.14x	0.13x	0.13x
EV / Revenue	0x	0x	0x	0x	0x	0.14x	0.13x	0.13x
EV / EBITDA	0x	0x	0x	0x	0x	8.39x	8.29x	8.25x
EV / EBIT	0x	0x	0x	0x	0x	12.6x	11.7x	11.4x
EV / FCF	0x	-0x	0x	-0x	0x	20.6x	26.5x	36.1x
FCF Yield	11.3%	-2.17%	17.4%	-4.12%	6.5%	4.85%	3.78%	2.77%
Dividend per Share ²	54	57	70	63	68	71	79.67	85
Rate of return	3.18%	3.36%	3.15%	2.98%	2.69%	2.88%	3.23%	3.44%
EPS ²	153.6	127.4	154.1	147.5	229.6	132.4	157	150.6
Distribution rate	35.2%	44.7%	45.4%	42.7%	29.6%	53.6%	50.8%	56.5%
Net sales ¹	2,585,643	2,696,069	2,858,500	2,961,051	3,104,064	3,193,819	3,288,778	3,340,075
EBITDA ¹	41,915	43,450	51,974	58,607	51,212	51,628	52,221	52,514
EBIT ¹	29,091	30,148	38,460	38,080	36,164	34,398	36,942	38,069
Net income ¹	32,182	25,786	29,558	27,389	41,746	23,414	27,149	26,886
Net Debt	-175,397	-156,267	-178,819	-141,540	-157,446	-	-	-
Reference price ²	1,699.00	1,696.00	2,222.50	2,111.50	2,528.00	2,469.00	2,469.00	2,469.00
Nbr of stocks (in thousands)	202,370	202,369	186,870	181,789	181,719	175,413	-	-
Announcement Date	5/16/22	5/15/23	5/14/24	5/15/25	5/15/26	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ALFRESA HOLDINGS CORPORATION	18.65x	-	-	2.88%	2.75B
ABBOTT LABORATORIES	35.13x	4.15x	15.59x	2.44%	184B
MEDTRONIC PLC	20.76x	3.57x	12.79x	2.94%	118B
STRYKER CORPORATION	24.35x	4.53x	15.49x	1.24%	111B
ESSILORLUXOTTICA	32.34x	3.11x	12.55x	2.2%	94.58B
CENCORA, INC.	18.14x	0.21x	13.15x	0.72%	63.13B
HOYA CORPORATION	31.66x	7.9x	20.3x	1.25%	55.66B
BECTON, DICKINSON AND COMPANY	39.25x	3.62x	12.32x	2.11%	53.9B
IDEXX LABORATORIES, INC.	37.34x	9.27x	25.93x	-.--%	43.42B
ALCON INC.	44.54x	3.36x	12.49x	0.52%	34.68B
Average	30.22x	4.41x	15.62x	1.63%	76.12B
Weighted average by Cap.	30.10x	4.15x	15.12x	1.83%